title: Pharmacovigilance and the italian medicines agency.
abstract: The new European Union (EU) regulations on pharmacovigilance require that the national systems are strengthened in order to fit the new requirements. The Italian Pharmacovigilance System, coordinated by the Italian Medicines Agency (AIFA), is made by local and regional structures. In 2007, a program for funding active pharmacovigilance projects in the Italian Regions was established by the National law. The AIFA is responsible for the preparation of guidelines aimed at the identification of research areas and for the approval of the projects submitted by the regions. In April 2012, the AIFA started a program of visits at the regional pharmacovigilance centers (RPCs), aimed at monitoring their performances, evaluating the quality of the activities in order to understand the main differences and discrepancies and with a view to start a program of harmonization of the procedures in place. The outcome of the visits program highlighted major differences among the quality management systems of the various centers; hence, AIFA has decided to launch an initiative to promote in the next months the harmonization of procedures. The synergy among AIFA, regional structures, RPCs, and local structure responsible for pharmacovigilance is needed in order to establish a robust pharmacovigilance system working in full compliance with the provisions of the new EU legislation.
authors.affiliation: Pharmacovigilance Unit, Italian Medicines Agency, Via del Tritone, Rome, Italy.
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Pimpinella
authors.affiliation: Pharmacovigilance Unit, Italian Medicines Agency, Via del Tritone, Rome, Italy.
authors.forename: Loriana
authors.initials: L
authors.lastname: Tartaglia
keywords: AIFA; Italian Medicines Agency; Italian Pharmacovigilance System; pharmacovigilance